USRE30314EExpiredUtility
Substituted pyrroloquinoxalinones and diones
Priority: Feb 25, 1977Filed: Apr 26, 1979Granted: Jun 24, 1980
Est. expiryFeb 25, 1997(expired)· nominal 20-yr term from priority
C07D 487/06C07D 241/44
6
PatentIndex Score
0
Cited by
4
References
8
Claims
Abstract
Substituted pyrroloquinoxalinones and diones, useful as anti-inflammatory and anti-thrombotic agents.
Claims
exact text as granted — not AI-modifiedI claim:
1. A compound of the formula: ##STR5## wherein R' is H or C 1 -C 3 alkyl; when taken singly, R 2 is H, C 1 -C 3 alkyl, C 1 -C 3 alkoxy, .Iadd.F .Iaddend.or Cl and R 3 is H; and R 2 and R 3 when taken together with the carbon atoms to which they are attached form a benzene ring; R 4 is H, Cl or F; R 5 is OH, H or phenyl; Y is O or H 2 ; Z is --CH 2 --CH 2 -- or --CHR 6 -- wherein R 6 is H or C 1 -C 3 alkyl.
2. A compound according to claim 1 in which R', R 2 , R 3 , R 4 and R 5 are H, Z is CHR 6 , R 6 is H and Y is O, said compound being 6-phenyl-1H-pyrrolo[1,2,3-de]quinoxalin-2,5(3H,6H)-dione.
3. A compound according to claim 1 in which R', R 2 , R 3 , R 4 and R 5 are H, Z is CHR 6 , R 6 is C 1 -C 3 alkyl and Y is O.
4. A compound according to claim 3 in which R 6 is ethyl, said compound being 3-ethyl-6-phenyl-1H-pyrrolo-[1,2,3de]quinoxalin-2,5(3H,6H)-dione.
5. A compound according to claim 3 in which R 6 is methyl, said compound being 3-methyl-6-phenyl-1H-pyrrolo-[1,2,3-de]quinoxalin-2,5(3H,6H)-dione.
6. A compound according to claim 1 in which R' is C 1 -C 3 alkyl, R 2 , R 3 , R 4 and R 5 are H, Z is CHR 6 , R 6 is H and Y is O.
7. A compound according to claim 6 in which R' is methyl, said compound being 1-methyl-6-phenyl-1H-pyrrolo-[1,2,3-de]quinoxalin-2,5(3H,6H)-dione.
8. A compound according to claim 6 in which R' is ethyl, said compound being 1-ethyl-6-phenyl-1H-pyrrolo-[1,2,3-de]quinoxalin-2,5(3H,6H)-dione.Join the waitlist — get patent alerts
Track USRE30314E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.